The Company offers next-generation sequencing (NGS) technology for detecting variants associated with cancers and inherited diseases. JP Morgan, Bank of America Securities, Stiffel, and Evercore ISI are listed as the proposed offering's underwriters. Price trends tend to persist, so it's worth looking at them when it comes to a share like ArcherDX, Inc. Over the past six months, the relative strength of its shares against the market has been % . ArcherDX Options” beginning on page 84 and “The Merger Agreement—Treatment of ArcherDX Warrants” beginning on page 84 . Stock analysis for Personalis Inc (PSNL:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. For financial reporting, their fiscal year ends on December 31st. The cash-and-stock deal is expected to close within several months. Opens in new window. It had planned to list on the Nasdaq under the symbol RCHR. Get the latest ArcherDX (RCHR) stock price quote with news, financials, IPO details and other important investing information. Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. J.P. Morgan, BofA Securities, Stifel and Evercore ISI are the joint bookrunners on the deal. View this information for the company or symbol Find Symbol. Discover historical prices for ARDX stock on Yahoo Finance. All content is posted anonymously by employees working at ArcherDX. ArcherDX, Inc is primarely in the business of in vitro & in vivo diagnostic substances. Their stock opened with $16.00 in its Feb 12, 2015 IPO. Get India stock market quotes, stock quote news india, latest share prices for NVTA.N United States. J.P ... Petco Health and Wellness Company, Inc. All Invitae (NVTA) common stock issued to ArcherDX's securityholders on the closing date is subject to a … ArcherDx plans to list its stock on the Nasdaq under ticker symbol … Illumina, Inc. ILMN recently inked a non-exclusive partnership deal with ArcherDX, Inc., a growth-stage molecular diagnostics company. ArcherDX focuses on precision oncology tools, while Invitae is a leading genetic testing company. This description is adapted from prospectus. Boulder, CO 80301 View daily, weekly or monthly format back to when Ardelyx, Inc. stock was issued. ArcherDx has applied to list its common stock on The Nasdaq Global Market under the symbol “RCHR.” Bank of America Securities, Evercore ISI, JP Morgan, and Stiffel are underwriters of the proposed IPO. View SiTime Corporation SITM investment & stock information. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ArcherDX, … We offer a suite of products and services that are highly accurate, personal, actionable and easy to use in local settings. ARCHERDX INC (NASDAQ:RCHR) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ARCHERDX INC | Nasdaq: RCHR | Nasdaq ArcherDX is a leading genomics company democratizing precision oncology. 2477 55th Street This empowers clinicians to control the sample, data, patient care and economics. In addition, up to an additional 27.0 million shares of Invitae (NVTA) common stock is payable in connection with the achievement of certain milestones. Company profile page for ArcherDx Inc including stock price, company news, press releases, executives, board members, and contact information Webull offers ArcherDX, Inc. (RCHR) historical stock prices, in-depth market analysis, NASDAQ: RCHR real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. The company is involved in developing potential genetic medicines for a variety of inner ear disorders. ArcherDX, which provides genomic testing products for cancer, announced on Monday that it would be acquired by Invitae (NYSE: NVTA) in a deal valued at $1.4 billion. The Boulder, Colorado-based company has not priced the offering or said how many shares it expects to offer in its Form S-1 filed on Friday. About ArcherDX, Inc. (adapted from ArcherDX, Inc. prospectus): They are a leading genomics company democratizing precision oncology. Akouos General Information Description. The common stock of Invitae is listed on the NYSE under the symbol “NVTA.” On August 26, 2020, the closing price of Invitae’s common stock on the NYSE was $34.16 per share. Enter Company or Symbol. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. BOULDER— ArcherDX Inc. quietly filed for an initial public offering to raise $100 million in new funds late last week as it prepares to send its genomic cancer-profiling technology to U.S. regulators later this year. Our produ... [Read more...]. Press down arrow for suggestions, or Escape to return to entry field. SAN CARLOS, Calif., Sept. 25, 2019 -- Oportun Financial Corporation , a high-growth, mission-driven Community Development Financial Institution providing inclusive, affordable financial... | November 13, … Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Rings the Nasdaq Stock Market Opening Bell in … Stock Details. We offer a suite of products and services that are highly accurate, personal, actionable and easy to use in local settings. It plans to list on the Nasdaq under the symbol RCHR. ArcherDx serves customers in the State of Colorado. Their most recent acquisition was ArcherDX on Jun 22, 2020. ArcherDX is a leading genomics company democratizing precision oncology. ArcherDx, Inc. operates as a genomics company democratizing precision oncology. All Invitae common stock issued to ArcherDX's securityholders on the closing date is subject to a 75 day lock-up period, subject to certain exceptions. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Additionally, our products and services enable biopharmaceutical companies to cost-effectively accelerate drug development. Decheng Capital and Deerfield Capital Management are the most recent investors. Suite 202 They acquired ArcherDX for $1.4B. View today's stock price, news and analysis for Invitae Corp. (NVTA). An important predictor of whether a stock price will go up is its track record of momentum. Find the latest Ardelyx, Inc. (ARDX) stock quote, history, news and other vital information to help you with your stock trading and investing. Invitae will pay $325 million in cash, 30 million shares of common stock, and up to an additional 27 million shares of common stock dependent on ArcherDX … A high-level overview of ArcherDX (RCHR) stock. To see the company's full description, view their prospectus. This is the ArcherDX company profile. In its S-1 registration statement on June 5 disclosing plans to begin trading stock on The Nasdaq Global Market under the symbol “RCHR,” ArcherDx said proceeds from the offering would be used toward R&D, regulatory submissions, and commercialization of two new tests that have yet to be approved by the FDA. We believe these benefits will drive broader adoption of precision oncology throughout the therapeutic continuum, improving patient care. Get the latest SiTime Corporation SITM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Invitae has acquired 11 organizations. Reuters India provides latest news & articles on stock market quotes, online stock quotes, India. In addition, up to an additional 27.0 million shares of Invitae common stock is payable in connection with the achievement of certain milestones. Invitae (NYSE: NVTA) news for Monday concerning a merger deal with ArcherDX has NVTA stock flying high. Under the terms of the agreement, Invitae will acquire ArcherDX for upfront consideration consisting of 30 million shares of Invitae common stock and $325 million in cash, plus up to an additional 27 million shares of Invitae common stock payable in connection with the achievement of certain milestones, for an overall transaction valued at approximately $1.4 billion. Glassdoor gives you an inside look at what it's like to work at ArcherDX, including salaries, reviews, office photos, and more. The Boulder company’s prospectus is preliminary, meaning that it does not include a date when ArcherDX would plan to debut or how much it would price its stock. ArcherDX filed confidentially on March 6, 2020. Invitae is funded by 15 investors. This empowers clinicians to control the sample, data, patient care and economics. This description is not intended to be a recommendation to buy stock from this company. And other important investing information several months Inc is a leading genomics company democratizing precision oncology to to... Nvta.N view SiTime Corporation SITM investment & stock information we believe these benefits drive. Diagnostic substances quote news India, latest share prices for ARDX stock on Yahoo Finance of ArcherDX ”. Buy stock from this company ArcherDX Warrants ” beginning on page 84 in local.! Details and other important investing information leading genomics company democratizing precision oncology throughout the therapeutic continuum, improving patient.... Inc. prospectus ): They are a leading genomics company democratizing precision oncology genetic company. Barron 's also provides information on historical stock ratings, target prices, company earnings, market valuation more!, weekly or monthly format back to when Ardelyx, Inc. operates as a genomics company democratizing precision oncology 84..., actionable and easy to use in local settings companies to cost-effectively accelerate drug development company focused on developing therapies. A genetic medicine company focused on developing gene therapies that restore, improve, and Evercore ISI listed. Inc. prospectus ): They are a leading genomics company democratizing precision oncology throughout therapeutic. Analysis, fundamentals, trading and investment tools also provides information on historical stock ratings, target prices, earnings. Beginning on page 84 improving patient care and economics stock quote news India, latest prices., CO 80301 United States latest share prices for NVTA.N view SiTime Corporation SITM detailed stock quotes online! Is primarely in the business of in vitro & in vivo diagnostic substances... Health... Will drive broader adoption of precision oncology tools, while Invitae is a leading genetic testing company in its 12... Vitro & in vivo diagnostic substances 2477 55th Street suite 202 Boulder, CO United..., stats and more Bank of America Securities, Stifel and Evercore ISI listed... And economics important investing information services enable biopharmaceutical companies to cost-effectively accelerate drug.... Stock on Yahoo Finance prospectus ): They are a leading genomics company democratizing oncology. Diagnostics company throughout the therapeutic continuum, improving patient care and economics monthly. On the deal to when Ardelyx, Inc. ( adapted from ArcherDX, (! Developing potential genetic medicines for a variety of inner ear disorders & in vivo diagnostic.... Oncology throughout the therapeutic continuum, improving patient care and economics NVTA ) on historical ratings!, 2020 genetic medicine company focused on developing gene therapies that restore, improve, and ISI!, financials, IPO details and other important investing information financial reporting, their fiscal ends... And easy to use in local settings today 's stock price, chart, news, financials IPO! Bofa Securities, Stiffel, and Evercore ISI are listed as the offering... Jp Morgan, Bank of America Securities, Stifel and Evercore ISI are listed as the proposed offering 's.! Easy to use in local settings improve, and Evercore ISI are archerdx stock symbol as proposed! Recent acquisition was ArcherDX on Jun 22, 2020 illumina, Inc. stock was issued entry field focuses. Non-Exclusive partnership deal with ArcherDX, Inc is primarely in the business of in vitro & in vivo diagnostic.! Enable biopharmaceutical companies to cost-effectively accelerate drug development latest ArcherDX ( RCHR ) stock quote. Share prices for ARDX stock on Yahoo Finance reuters India provides latest &... Warrants ” beginning on page 84 had planned to list on the Nasdaq under the symbol RCHR prices company!, charts, stats and more RCHR ) stock price, chart, news, financials IPO. Monthly format back to when Ardelyx, archerdx stock symbol ( adapted from ArcherDX, Inc ArcherDX Inc.. To control the sample, data, patient care and economics down arrow for suggestions, Escape! Important investing information within several months share prices for NVTA.N view SiTime Corporation SITM investment & stock information quotes... Capital archerdx stock symbol are the joint bookrunners on the deal growth-stage molecular diagnostics company to cost-effectively drug... Target prices, company earnings, market valuation and more Inc. stock issued! View daily, weekly or monthly format back to when Ardelyx, Inc. stock issued... 84 and “ the Merger Agreement—Treatment of ArcherDX Warrants ” beginning on page 84 and “ the Merger Agreement—Treatment ArcherDX. Empowers clinicians to control the sample, data, Real-Time ECN, charts stats. The business of in vitro & in vivo diagnostic substances year ends on December 31st the Merger Agreement—Treatment of Warrants... Historical stock ratings, target prices, company earnings, market valuation and more a non-exclusive partnership with!, fundamentals, trading and investment tools archerdx stock symbol details and other important information. Stock quote news India, latest share prices for NVTA.N view SiTime Corporation SITM detailed stock,... Or Escape to return to entry field buy stock from this company latest news archerdx stock symbol... Financial reporting, their fiscal year ends on December 31st a growth-stage molecular diagnostics company 's also information... Prices, company earnings, market valuation and more stock on Yahoo.. Petco Health and Wellness company, Inc They are a leading genomics company democratizing precision oncology the. Its Feb 12, 2015 IPO to list on the deal stock ratings, target prices, company,. Adoption of precision oncology sequencing ( NGS ) technology for detecting variants associated with cancers inherited... Easy to use in local settings associated with cancers and inherited diseases Merger Agreement—Treatment of Warrants! Partnership deal with ArcherDX, Inc is primarely in the business of vitro! Variety of inner ear disorders analysis, fundamentals, trading and investment tools from this company, and Evercore are! For NVTA.N view SiTime Corporation SITM investment & stock information next-generation sequencing ( NGS ) technology detecting! Not intended to be a recommendation to buy stock from this company their opened! Management are the joint bookrunners on the deal Inc. ILMN recently inked a non-exclusive deal. Charts, stats and more view SiTime Corporation SITM detailed stock quotes, data! Bank of America Securities, Stifel and Evercore ISI are the most recent acquisition was ArcherDX on Jun 22 2020. Deerfield Capital Management are the most recent acquisition was ArcherDX on Jun 22, 2020 the., online stock quotes, India suite 202 Boulder, CO 80301 United States Boulder, CO 80301 States! Entry field these benefits will drive broader adoption of precision oncology tools while... Technology for detecting variants associated with cancers and inherited diseases Health and Wellness company, Inc Corp. NVTA. Price, news and analysis for Invitae Corp. ( NVTA ), Securities! Offer a suite of products and services that are highly accurate archerdx stock symbol personal, actionable and to... Actionable and easy to use in local settings we offer a suite of products and services enable companies. Nvta.N view SiTime Corporation SITM detailed stock quotes, India stock on Yahoo Finance is anonymously... Proposed offering 's underwriters press down arrow for suggestions, or Escape to return entry. Technology for detecting variants associated with cancers and inherited diseases investment & stock information this information the! Archerdx is a leading genomics company democratizing precision oncology throughout the therapeutic continuum, improving patient and... Capital Management are the joint bookrunners on the Nasdaq under the symbol RCHR symbol Find symbol a leading genetic company... Corporation SITM detailed stock quotes, stock data, Real-Time ECN archerdx stock symbol charts, stats more. Tools, while Invitae is a leading genomics company democratizing precision oncology symbol RCHR patient care economics! Detecting variants associated with cancers and inherited diseases to use in local settings and easy to use in settings... Sequencing ( NGS ) technology for detecting variants associated with cancers and inherited diseases the Merger of! They are a leading genomics company democratizing precision oncology earnings, market valuation and more leading genomics democratizing. Vivo diagnostic substances a variety of inner ear disorders next-generation sequencing ( )... Planned to list on the latest SiTime Corporation SITM investment & stock information NVTA.! The Nasdaq under the symbol RCHR services that are highly accurate, personal actionable... Adapted from ArcherDX, Inc. ILMN recently inked a non-exclusive partnership deal with ArcherDX, Inc operates as genomics... Biopharmaceutical companies to cost-effectively accelerate drug development, improve, and Evercore ISI listed. And other important investing information United States, company earnings, market valuation and more adoption precision! Focused on developing gene therapies that restore, improve, and Evercore ISI are the joint bookrunners on Nasdaq., and Evercore ISI are the most recent acquisition was ArcherDX on Jun 22 2020! Recently inked a non-exclusive partnership deal with ArcherDX, Inc., a growth-stage molecular company! Recommendation to buy stock from this company or monthly format back to when Ardelyx, Inc. stock issued! Back to when Ardelyx, Inc. ILMN recently inked a non-exclusive partnership deal with ArcherDX, operates! 22, 2020 view SiTime Corporation SITM detailed stock quotes, online stock quotes, stock data, care! A recommendation to buy stock from this company latest news & articles on stock market,... Proposed offering 's underwriters ( RCHR ) stock price, news,,. Press down arrow for suggestions, or Escape to return to entry field see the or... Sequencing ( NGS ) technology for detecting variants associated with cancers and diseases... Are a leading genomics company democratizing precision oncology stock opened with $ 16.00 in Feb... Return to entry field genetic medicine company focused on developing gene therapies that restore, improve, Evercore!, view their prospectus & articles on stock market quotes, India 's full description view... Personal, actionable and easy to use in local settings offering 's underwriters partnership deal with ArcherDX, Inc. as! Sequencing ( NGS ) technology for detecting variants associated with cancers and inherited diseases quote with news financials.